Efficacy of an occupational intervention for quality of work life in ADHD: A randomized controlled trial protocol

IF 1.9 3区医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL

Contemporary clinical trials Pub Date : 2025-06-30 DOI:10.1016/j.cct.2025.107997

Chloé Voyer , Marc Corbière , Patrizia Villotti , Alina N. Stamate , Geneviève Sauvé

{"title":"Efficacy of an occupational intervention for quality of work life in ADHD: A randomized controlled trial protocol","authors":"Chloé Voyer , Marc Corbière , Patrizia Villotti , Alina N. Stamate , Geneviève Sauvé","doi":"10.1016/j.cct.2025.107997","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>While psychosocial interventions for ADHD in children are well-established, there is a gap in addressing ADHD symptoms that persist into adulthood, particularly those impacting occupational functioning. Adults living with ADHD often face challenges in the workplace related to time management, regulating attention, task prioritization, and meeting deadlines.</div></div><div><h3>Methods</h3><div>This study will evaluate the efficacy of a workplace intervention designed to improve the quality of work life in adults living with possible ADHD. A single-blind randomized controlled trial will compare an 8-week virtual psychosocial intervention to an active control group, with quality of work life as the primary outcome. Secondary outcomes will include self-reported measures related to work such as job satisfaction, psychological needs and well-being, self-esteem, self-efficacy, cognitive functioning, self-compassion, and quality of work relationships. Outcomes will be assessed at baseline, post-intervention, and at 3, 6, 9, and 12-month follow-up. In parallel, an optional awareness raising video will engage workplace stakeholders to improve ADHD literacy, reduce stigma, and offer neuroinclusive management strategies. Intention-to-treat analyses will use linear mixed-effects models.</div></div><div><h3>Discussion</h3><div>A participatory research approach was used to co-design the intervention material with workplace managers, community representatives, service providers and adults with lived experience. The research team will disseminate findings in scientific journals, conferences, and by sharing bilingual intervention materials with service providers and adults living with ADHD. This study fills a gap in addressing ADHD in the workplace, with findings that will inform intervention practices and improve workplace inclusion.</div><div><em>Trial registration:</em> This study was registered at ClinicalTrials.gov (<span><span>NCT06774378</span><svg><path></path></svg></span>) on January 17, 2025.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"155 ","pages":"Article 107997"},"PeriodicalIF":1.9000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714425001910","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background

While psychosocial interventions for ADHD in children are well-established, there is a gap in addressing ADHD symptoms that persist into adulthood, particularly those impacting occupational functioning. Adults living with ADHD often face challenges in the workplace related to time management, regulating attention, task prioritization, and meeting deadlines.

Methods

This study will evaluate the efficacy of a workplace intervention designed to improve the quality of work life in adults living with possible ADHD. A single-blind randomized controlled trial will compare an 8-week virtual psychosocial intervention to an active control group, with quality of work life as the primary outcome. Secondary outcomes will include self-reported measures related to work such as job satisfaction, psychological needs and well-being, self-esteem, self-efficacy, cognitive functioning, self-compassion, and quality of work relationships. Outcomes will be assessed at baseline, post-intervention, and at 3, 6, 9, and 12-month follow-up. In parallel, an optional awareness raising video will engage workplace stakeholders to improve ADHD literacy, reduce stigma, and offer neuroinclusive management strategies. Intention-to-treat analyses will use linear mixed-effects models.

Discussion

A participatory research approach was used to co-design the intervention material with workplace managers, community representatives, service providers and adults with lived experience. The research team will disseminate findings in scientific journals, conferences, and by sharing bilingual intervention materials with service providers and adults living with ADHD. This study fills a gap in addressing ADHD in the workplace, with findings that will inform intervention practices and improve workplace inclusion.

Trial registration: This study was registered at ClinicalTrials.gov (NCT06774378) on January 17, 2025.

查看原文本刊更多论文

职业干预对ADHD患者工作生活质量的影响：一项随机对照试验方案。

背景：虽然儿童ADHD的心理社会干预措施已经建立，但在处理持续到成年的ADHD症状方面存在差距，特别是那些影响职业功能的症状。患有多动症的成年人经常在工作场所面临与时间管理、调节注意力、任务优先级和完成截止日期相关的挑战。方法：本研究将评估工作场所干预的效果，旨在改善可能患有多动症的成年人的工作生活质量。一项单盲随机对照试验将以工作生活质量为主要结果，将为期8周的虚拟心理社会干预与积极对照组进行比较。次要结果将包括与工作相关的自我报告措施，如工作满意度、心理需求和幸福感、自尊、自我效能、认知功能、自我同情和工作关系质量。结果将在基线、干预后以及3、6、9和12个月的随访中进行评估。与此同时，一个可选的提高意识的视频将吸引工作场所的利益相关者提高对多动症的认识，减少耻辱感，并提供神经包容性管理策略。意向治疗分析将使用线性混合效应模型。讨论：采用参与式研究方法与工作场所管理者、社区代表、服务提供者和有生活经验的成年人共同设计干预材料。研究小组将在科学期刊、会议上传播研究结果，并与服务提供者和患有多动症的成年人分享双语干预材料。这项研究填补了在解决工作场所多动症方面的空白，其研究结果将为干预实践提供信息，并改善工作场所的包容性。试验注册：本研究于2025年1月17日在ClinicalTrials.gov （NCT06774378）注册。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Contemporary clinical trials 医学-药学

CiteScore

3.70

自引率

4.50%

发文量

281

审稿时长

44 days

期刊介绍： Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.